Unitedhealth Group Inc (NYSE: UNH) closed the day trading at $456.00 up 0.06% from the previous closing price of $455.74. In other words, the price has increased by $+0.26 from its previous closing price. On the day, 4531195 shares were traded. UNH stock price reached its highest trading level at $457.20 during the session, while it also had its lowest trading level at $453.59.
Ratios:
For a better understanding of UNH, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.70.
On March 06, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $551.
HSBC Securities Downgraded its Hold to Reduce on December 18, 2023, whereas the target price for the stock was revised from $550 to $480.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 08 ’24 when McSweeney Erin sold 1,236 shares for $483.48 per share. The transaction valued at 597,582 led to the insider holds 9,364 shares of the business.
ROOS THOMAS E sold 858 shares of UNH for $451,128 on Feb 23 ’24. The Chief Accounting Officer now owns 32,289 shares after completing the transaction at $525.79 per share. On Feb 16 ’24, another insider, THOMPSON BRIAN R, who serves as the CEO, UnitedHealthcare of the company, sold 28,943 shares for $521.00 each. As a result, the insider received 15,079,303 and left with 25,543 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 420.40B and an Enterprise Value of 453.31B. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.12, and their Forward P/E ratio for the next fiscal year is 14.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.13 while its Price-to-Book (P/B) ratio in mrq is 4.75. Its current Enterprise Value per Revenue stands at 1.22 whereas that against EBITDA is 12.48.
Stock Price History:
Over the past 52 weeks, UNH has reached a high of $554.70, while it has fallen to a 52-week low of $445.68. The 50-Day Moving Average of the stock is 496.98, while the 200-Day Moving Average is calculated to be 508.70.
Shares Statistics:
Over the past 3-months, UNH traded about 4.32M shares per day on average, while over the past 10 days, UNH traded about 4.71M shares per day. A total of 924.00M shares are outstanding, with a floating share count of 920.24M. Insiders hold about 0.18% of the company’s shares, while institutions hold 90.46% stake in the company. Shares short for UNH as of Mar 15, 2024 were 7.29M with a Short Ratio of 1.69, compared to 6.34M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.79% and a Short% of Float of 0.79%.
Dividends & Splits
UNH’s forward annual dividend rate is 7.52, up from 7.29 a year ago. Against a Trailing Annual Dividend Yield of 1.60%, it implies a Forward Annual Dividend Yield of 1.53%. The stock’s 5-year Average Dividend Yield is 1.37. The current Payout Ratio is 30.55% for UNH, which recently paid a dividend on Mar 19, 2024 with an ex-dividend date of Mar 08, 2024. Stock splits for the company last occurred on May 31, 2005 when the company split stock in a 2:1 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 21 analysts. On average, analysts expect EPS of $6.2 for the current quarter, with a high estimate of $6.3 and a low estimate of $5.93, while EPS last year was $5.72. The consensus estimate for the next quarter is $6.36, with high estimates of $6.51 and low estimates of $5.97.
Analysts are recommending an EPS of between $25.97 and $24.91 for the fiscal current year, implying an average EPS of $25.54. EPS for the following year is $28.83, with 25 analysts recommending between $29.36 and $28.01.
Revenue Estimates
16 analysts predict $91.68B in revenue for the current quarter. It ranges from a high estimate of $93.09B to a low estimate of $89.12B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $89.78B, an estimated increase of 2.10% from the year-ago figure.
A total of 21 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $372.51B, while the lowest revenue estimate was $364.46B, resulting in an average revenue estimate of $369.56B. In the same quarter a year ago, actual revenue was $342.52B, up 7.90% from the average estimate. Based on 21 analysts’ estimates, the company’s revenue will be $398.13B in the next fiscal year. The high estimate is $404.19B and the low estimate is $381.68B. The average revenue growth estimate for next year is up 7.70% from the average revenue estimate for this year.
